Cat. No.: X23-10-ZQ999
JAK inhibitor PF-06651600, Purity ≥98%
Synonym: 1792180-81-4; Ritlecitinib; PF-06651600; 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one; JAK inhibitor
- CAS Number: 1792180-81-4
- Compound CID: 118115473
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Properties
Description
PF-06651600 is a potent and irreversible JAK3-selective inhibitor. It targets JAK3.
Molecular Formula
C15H19N5O
Identity
Confirmed by NMR/HPLC/MS.
Applications
PF-06651600 can be utilized as a JAK3 inhibitor to explore roles in immune response and inflammation.
Related Products
-
JAK inhibitor JAK/HDAC-IN-1, Purity ≥98%
-
JAK inhibitor 1,2,3,4,5,6-Hexabromocyclohexane, Purity ≥98%
-
JAK inhibitor Abrocitinib, Purity ≥98%
-
JAK inhibitor AZ-3, Purity ≥98%
-
JAK inhibitor AZ-960, Purity ≥98%
-
JAK inhibitor AZD1480, Purity ≥98%
Quick Links